Growing Pharmaceutical Contract Manufacturing Propels the North American Healthcare CDMO Market

The North American healthcare CDMO market is projected to grow at a significant CAGR during the forecast period (2020-2026). The market is mainly driven due to significant growth in pharmaceutical contract manufacturing in the US and Canada. Outsourcing the manufacturing services in the pharmaceutical industry enables the companies to divert the workforce to other processing tasks, which as a result makes monetary savings and reduces the time for R&D activities. The drug development companies can save up to 30-35% of the drug development cost via contract manufacturing procedure. Therefore, to remain competitive in the market, contract manufacturing is considered crucial support for pharmaceutical companies. 

Browse the full report description North American Healthcare Contract Development And Manufacturing Organization (CDMO) Market Size, Share & Trends Analysis Report by Services (Contract Development and Contract Manufacturing) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/north-american-healthcare-cdmo-market

In the region, several pharmaceutical companies are focused on finding ways to minimize the cost of drugs, which in turn forced them to outsource drug manufacturing services. In January 2019, Cambrex Corp. acquired Avista Pharma Solutions to strengthen the position of Cambrex as a prominent fully integrated small molecule contract development and manufacturing organization (CDMO). Avista Pharma Solutions was a contract development, manufacturing, and testing organization. Avista’s four sites in Durham, NC, Longmont, CO, Agawam, MA, and Edinburgh, Scotland, UK will be integrated into the global network of Cambrex. This will expand the company’s geographical presence and strengthen its manufacturing capabilities. 

Market Coverage

Key Questions Addressed by the Report

• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID forecast

o Most affected region/segment

o Recommendations 

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North American healthcare CDMO Market – Segmentation

By Services

• Contract Development 

o Clinical

o Preclinical

o Laboratory Services

• Contract Manufacturing

o Active Pharmaceutical Ingredients( API) 

o Finish Dosage Formulations 

o Medical Devices

North American Healthcare CDMO Market – Segmentation by Region

• United States
• Canada